Company Filing History:
1 out of 3,684 
1 out of 71 
Years Active: 2022
Title: Arathi Krishnakumar: Innovator in Cancer Treatment
Introduction
Arathi Krishnakumar is a notable inventor based in Chesterfield, NJ (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods.
Latest Patents
Arathi holds a patent for a method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist. This patent outlines methods of identifying and using PSGL-1 antagonists, which include antibodies that bind PSGL-1 and VISTA. These antibodies inhibit PSGL-1 binding to VISTA, particularly at acidic pH levels, and involve PSGL-1 and VISTA extracellular domain polypeptides. Her work is crucial in advancing cancer treatment methodologies.
Career Highlights
Throughout her career, Arathi has worked with prominent companies in the pharmaceutical industry, including Bristol-Myers Squibb Company and Five Prime Therapeutics, Inc. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in cancer therapies.
Collaborations
Arathi has collaborated with esteemed colleagues such as Robert J. Johnston and Andrew Rankin. These partnerships have further enhanced her research capabilities and innovation in the field.
Conclusion
Arathi Krishnakumar is a pioneering inventor whose work in identifying PSGL-1 antagonists is paving the way for new cancer treatments. Her contributions to the pharmaceutical industry and collaborations with other professionals highlight her commitment to advancing medical science.